column
    Research Progress of Immunotherapy in Triple-Negative Breast Cancer
    ZHANG Ting-feng, YANG Ci-qiu, WANG Kun
    2021, 21(2): 65-70. DOI: 10.12019/j.issn.1671-5144.2021.02.001
    Abstract PDF
    IMpassion130: The Efficacy of Atezolizumab Plus Nab-Paclitaxel Treatment in Comparison With Nab-Paclitaxel Alone as First-Line Treatment of Advanced Triple-Negative Breast Cancer
    YANG Mei, SHEN Bo
    2021, 21(2): 71-75. DOI: 10.12019/j.issn.1671-5144.2021.02.002
    Abstract PDF
    Pambrolizumab Is Expected to Change the Choice of First-Line Treatment for Advanced Triple-Negative Breast Cancer: Review the KEYNOTE-355 Study
    ZHANG Shao-hua, ZHANG Jun-sheng
    2021, 21(2): 76-78. DOI: 10.12019/j.issn.1671-5144.2021.02.003
    Abstract PDF
    Re-Ignite the Hope of Neoadjuvant Immunotherapy for Early Triple-Negative Breast Cancer
    LIN Yu-xiang, SONG Chuan-gui, YUAN Jiao-mei
    2021, 21(2): 79-82. DOI: 10.12019/j.issn.1671-5144.2021.02.004
    Abstract PDF
    The First Prospective Randomized Controlled Phase ⅢClinical Study of Pembrolizumab Combined With Chemotherapy as Neoadjuvant Treatment for Early Triple-Negative Breast Cancer
    YANG Ci-qiu, WANG Kun, CHEN Yuan-qi
    2021, 21(2): 83-86. DOI: 10.12019/j.issn.1671-5144.2021.02.005
    Abstract PDF
    The Effect of Intrathecal Injection of Morphine Combined With Dexmedetomidine on the Analgesic Effect in Patients With Severe Advanced Colorectal Cancer
    HUANG Dan, NI Ming, YU Chuang-qin
    2021, 21(2): 87-92. DOI: 10.12019/j.issn.1671-5144.2021.02.006
    Abstract PDF
    Analysis of the Correlation Between PPARγ Promoter Methylation and Myocardial Infarction
    LUO Mei, YAN Shi-qi, CAO Gui-qiu, WANG Juan
    2021, 21(2): 93-99. DOI: 10.12019/j.issn.1671-5144.2021.02.007
    Abstract PDF
    Analysis of Risk Factors of Blood Transfusion During Meningioma Resection
    HUANG Yi, JIANG Xue-gao, LI Jian-hua, TANG Jie, GONG Yue-yong, ZHENG Yuan
    2021, 21(2): 100-104. DOI: 10.12019/j.issn.1671-5144.2021.02.008
    Abstract PDF
    Efficacy and Safety of Transbronchial Cryobiopsy in the Etiologic Diagnosis of Interstitial Lung Disease
    WANG Yu-chao, LUO Shao-hua, CHEN Ping-ping, LI Xiu-yu, XU Han-yi, CUI Jing-hua, CHEN Jing-jing, XU Xiao-yi, ZHANG Yun-hui, LI Jing
    2021, 21(2): 105-112. DOI: 10.12019/j.issn.1671-5144.2021.02.009
    Abstract PDF
    Molecular Features of Resistance to Crizotinib in Advanced Non-Small-Cell Lung Cancer With ALK Rearrangement
    DENG Qiu-mei, WANG Han-min, KANG Jin, YANG Jin-ji
    2021, 21(2): 113-117. DOI: 10.12019/j.issn.1671-5144.2021.02.010
    Abstract PDF
    The Influence of Design Type and Variable Type on the Appropriate Choice of Statistical Methods for Clinical Medical Research
    WU Jun-lin, TANG Xue-li, CHEN Xia, DAI Hao-ran, LI Jia-bin, HUANG Yan-jun, HUANG Guo-ping
    2021, 21(2): 118-123. DOI: 10.12019/j.issn.1671-5144.2021.02.011
    Abstract PDF
    Radical Treatments After Downstaging of Hepatocellular Carcinoma
    ZOU Wei, LV Ling, SHI Feng, CHEN Xiao-ming
    2021, 21(2): 124-128. DOI: 10.12019/j.issn.1671-5144.2021.02.012
    Abstract PDF